zeiss medical technology company presentation · 2020-05-20 · zeiss. company history. company...

ZEISS Medical Technology Company Presentation

Insights2017/2018

ContentZEISS Medical Technology

1 The ZEISS Group

2 ZEISS Medical Technology at a glance

3 Fascinating Facts

4 Product Portfolio

5 Solution Provider

6 Global MEGS Trends

7 Corporate Social Responsibility

Company Presentation – ZEISS Medical Technology

InsightsZEISS Medical Technology

The ZEISS Group


15 millioncataract operations are performed annually around the world using surgical systems from ZEISS

1st Picture of the surface of the Moon taken with lenses from ZEISS

Every secondtwo people decideto purchase eyeglass lenses from ZEISS

35 Nobel prize-winnersput their trust in ZEISS microscopes to see more

3 Technical Oscarsfor helping leading movie-makers capture perfect moments on film

9,100 Stars can be projected in planetariums using ZEISS optics

The Power of ZEISS170 years of company history in Innovations


Their mission Cutting-edge research Extreme precision and maximum quality

Responsibility to society

Carl Zeiss Ernst Abbe

ZEISSThe company founders


ZEISSCompany history


1846 1875 1889 since 1890 since 1894 after 1945 1991 2004since 1926 2016

Stock corporationZEISS is transformed into a stock corporation – the Carl Zeiss Foundation remains the sole stockholder

Carl Zeissopens a workshop for precision engineering and optics in Jena

Carl Zeiss Foundationcreated by Ernst Abbe

Ernst Abbebecomes part owner

DiversificationInnovative products open up new business

Reunificationof the two separated companies

ConsolidationStarts with the founding of Zeiss Ikon AG

PartitionJena: expropriatedOberkochen: new factory

First non-German subsidiaryin London marks the start of global expansion

200th birthday of Carl Zeiss(1816–1888)

Innovation is part of the ZEISS DNA For more than 170 years


1857 1872 1894 1902 1912 1923 1953 1973 1977 1994 2009 2012 2013 2014 20151996 2000

PiWebQuality data

management for industry

LSM 880 Airyscan

ReLEx SMILE, VisuMax Femtosecond laser

Freeform technologyfor individually produced eyeglass lenses

ZEISS UMM 500First coordinatemeasuring machine

ZEISS AIMS system Photomask inspection system for chip production

DriveSafe eyeglass lenses

X-ray microscope

EUV lithographyFirst EUV optics in volume production

FirstOCT

S-Planar® 10/0.42lithography optics

Firstsurgical microscope

Large ophthalmoscope and ZEISS PUNKTAL eyeglass lenses

Binocularswith increased objective distance

Firstcompound microscope

Abbe's theoryof microscoperesolution

ZEISS Tessar

ProjectionplanetariumFirst presentation (Munich)

2016

Over 30 Nobel laureates worldwide useZEISS instruments to achieve progress in science


1906 1911 1925 1952 1953 1967 1991 1995 1999 2001 20021905 20082006 20112010 2012 2013 2014

Robert KochPhysiology/medicine

Alvar GullstrandPhysiology/medicine

Manfred Eigen Chemistry

Christiane Nüsslein-Volhard Physiology/medicine

Sir Paul M. Nurse Leland H. HartwellTimothy Hunt Physiology/medicine

Craig C. Mello Andrew Z. FirePhysiology/medicine

Andre GeimKonstantin NovoselovPhysics

Eric BetzigStefan W. HellWilliam E. MoernerChemistry

Sir John B. GurdonShinya YamanakaPhysiology/medicine

John O'Keefe May-Britt Moser Edvard I. MoserPhysiology/medicine

Eric A. CornellPhysics

Richard Adolf Zsigmondy Chemistry

Bert Sakmann Erwin Neher Physiology or medicine

Harald zur Hausen Physiology/medicine

Osamu ShimomuraMartin ChalfieRoger TsienChemistry

Sidney Brenner H. Robert HorvitzJohn E. Sulston Physiology/medicine Dan Shechtman

Chemistry

Santiago Ramón y Cajal Camillo GolgiPhysiology/medicine

Frits ZernikePhysics

Günter Blobel Physiology/medicine

Ahmed A. ZewailChemistry

In close collaboration with ZEISS staff

In closecollaboration with ZEISS staff



In closecollaboration with ZEISS staff



As of 30 September 2018

billion euros revenue

772million euros earnings (EBIT)≈30,000employees (worldwide)

Financial highlights2018/18

5.817

Around30 production sites

Around30,000 employees

Represented in over50 countries

Over60 sales andservice sites

Around25 research anddevelopment centers

HeadquartersOberkochen

Represented worldwideSites


*As per 30 September 2018 **The values deviate from the published figures of Carl Zeiss Meditec AG as a result of different consolidation models.

Medical Technology**

1,546* billion euros revenue ≈ 4,900 employees

Semiconductor Manufacturing Technology

1,531* million euros revenue ≈ 3,400 employeesIndustrial Quality & Research

1,549* million euros revenue ≈ 6,800 employees

Consumer Markets

1,106* million euros revenue ≈ 10,500 employees


Segments2017/18


ZEISS Medical Technology at a glance


With innovations for ophthalmology and microsurgery, ZEISS Medical Technology is contributing to progress in medicine. Our products and solutions aim to help physicians to improve patient outcomes and their patients’ quality of life.

Improving quality of life


Pioneering Medical TechnologyZEISS Medical Technology

ZEISS Medical TechnologyAspiration & Vision


Our AspirationEnable doctors to efficiently and effectively improve the quality of life of patients and drive the progress of medicine

Our VisionBecome the partner of choice for the doctors in our segments.


As a world-leading medical technology company, we drive progress in medicine, enabling doctors to achieve the best possible outcomes for their patients

Microsurgery

Complete product range of visualization solutions for minimally invasive surgical treatments (e.g. Neuro, ENT, spinal, dental)

Intraoperative diagnostics to enhance effectiveness and safety of surgical procedures complete with cutting-edge video technology and three-dimensional imaging

Visualization Surgical OncologySurgical Ophthalmology

Ophthalmic Devices

Comprehensive solutions to diagnose and treat eye diseases

Systems and consumables for cataract, retinal and refractive surgery

Focus on networking of systems and the integrated management of data, to make workflows in hospitals and medical practices efficient

Ophthalmic Diagnostics

Refractive Laser Surgery

ZEISS Medical TechnologyDriving Progress in Medicine through Innovation

All figures as reported.

Americas APACEMEA

Growth & Revenue Split by Regions

SBU: Strategic Business Unit

Microsurgery Ophthalmic Devices

Growth & Revenue Split by SBUs

Results at a Glance (FY 17/18)Broad Product Portfolio, Balanced Regional Set-up


31.7% 29.5% 38.8% 73 %27 %

Diagramm1

EMEA

Americas

Asien/Pazific

Spalte1

34.8

34.5

30.7

Tabelle1

Spalte1

EMEA34.8

Americas34.5

Asien/Pazific30.7

Ziehen Sie zum Ändern der Größe des Diagrammdatenbereichs die untere rechte Ecke des Bereichs.

Diagramm1

EMEA

Americas

Asien/Pazific

Spalte1

34.8

34.5

30.7

Tabelle1

Spalte1

EMEA34.8

Americas34.5

Asien/Pazific30.7


Diagramm1

EMEA

Americas

Asien/Pazific

Spalte1

34.8

34.5

30.7

Tabelle1

Spalte1

EMEA34.8

Americas34.5

Asien/Pazific30.7


Diagramm1

EMEA

Americas

Spalte1

72.8

27.2

Tabelle1

Spalte1

EMEA72.8

Americas27.2

Asien/Pazific30.7


Tabelle2

Diagramm1

EMEA

Americas

Spalte1

72.8

27.2

Tabelle1

Spalte1

EMEA72.8

Americas27.2

Asien/Pazific30.7


Tabelle2

Headquarters in Jena, Germany

Around 3,050 employees worldwide

Listed on the TecDAX

59% of shares held by Carl Zeiss AG


Significant sales growth over the last five years

Carl Zeiss MeditecCompany Snapshot

11/12 12/13 13/14 14/15

861,9 906,4 909,3 1.040,1

Revenue in € millionen

15/16

1.088,4

16/17

1.189,9 1.280,99

17/18 11/12 12/13 13/14 14/15 15/16

122,9 133,8 120,7 130,6 154,3

EBIT in € millionen

180,8

16/17 17/18

197,1

Global PresenceMore Than 30 Sites Worldwide



Executive BoardCarl Zeiss Meditec AG

Dr. Ludwin Monz President & CEO Carl Zeiss Meditec AG

Justus Felix WehmerCFO Carl Zeiss Meditec AG

Jan Willem de ClerMember of the Management Board Carl Zeiss Meditec AG


Fascinating Facts


Fascinating FactsZEISS Medical Technology


Did you know that ...

... an amazing 4 million surgeries have been performed with the OPMI PENTERO 900 or the OPMI Pentero around the globe?

… around 75 percent of all cataract patients come into contact with a product from ZEISS during their treatment?

… over 15 million cataract operations are performed with ZEISS surgical systems all over the world every year?

… today, more than half of all Optical Coherence Tomography Systems (OCT) in ophthalmological practices are ZEISS OCTs?

… in FY 15/16, ZEISS Medical Technology has invested 12.3 percent of its revenue in Research & Development?


Product Portfolio


Products

OphthalmicDevices

SBU

Microsurgery

Radiotherapy

Surgical Ophthalmology

Visualisation & Microsurgery

Ophthalmic Diagnostics

Refractive Surgery

Segments

Broad Product PortfolioWe Offer Our Customers an Extensive Portfolio

Private practitioners

Clinics

Ambulatorysurgerycenters

Hospitals

Customers



Solution Provider


More than 100 Years of Leadership in Medical TechnologyGold Standard Products Defining the Market


IOLMaster® VisuMax®System

OPMI® HFA™Perimeter

OCT 1Slit lamp

OPMI®PENTERO

Pace-setting innovation for more than 100 years

Data Management Solution

IOLMaster®

Diagnosis Surgery

The Cataract WorkflowIntegrating Products into Systems

For Better Treatment Efficiencies and Improved Patient Outcomes

VISALIS phaco® CALLISTO eye

®OPMI® LUMERA®

AT LISA tri®


Identifiying needs & providing solutions

ImplementingIn the practice and the OR Training Service Clinical application specialists Technical support

Ongoing serviceand support for maximum uptime & practice efficiency.

Bringing Innovation and Patients Together



Global MEGA Trends


Technological Change

Long-term trends significantly boost our growthGlobal MEGA Trends


DemographicChange

Globalisation

Global MEGA TrendsSeveral Key Trends are Influencing Our Markets

Aging of the population and growing affluence1 Increasing information access and awareness2 Budget constraints3

Growing patient load, growing expectations4 Rising access to health care in RDEs5Company Presentation – ZEISS Medical Technology

Demographic ChangeThe Proportion of Older People is Growing


DemographicChange

Demographic ChangeComprehensive Solutions for Typical Age-related Diseases

„The proportion of older people in theoverall population is growing in manyparts of the world. We offer comprehensive solutions for thediagnosis and treatment of typical age-related diseases.“

Dr. Ludwin MonzPresident & CEO


Demographic ChangeInnovations for Age-related Diseases

33

CALLISTO eye® assists cataract surgeons with the precision alignment of IOLs

40 %

Lens clouded by cataract

Vision with cataractNormal vision

of the population will develop cataracts


Technological ChangeThe Medical Sector is Rapidly Changing


Technological Change

Patients have high expectations of clinical outcomes

Minimally-invasive refractive laser surgerywith ReLEx SMILE

ReLEx® SMILE: Minimally invasive treatment method sets new standards in refractive surgery


Technological LeadershipPioneering Refractive Laser Technology

Brilliant visualizationin Neurosurgerywith ZEISS KINEVO 900


Technological LeadershipThe Next Generation of Surgical Microscopes

Technological LeadershipInnovation in Brain Tumor Treatment

Brain tumor treatmentwith INTRABEAM 600


GlobalisationThe World is Converging


Globalisation

GlobalisationWe Are Well Aware of Our Customers‘ Demands

„Through our global network we are well aware ofour customers‘ demands. We use this knowledgeto define standards which we then put intopractice through international training courses.“

Dr. Ludwin MonzPresident & CEO


Global KnowledgeSharing Knowledge Through Worldwide Training with the ZEISS ACADEMY

Employee trainingin Jena

Training workshop In Hong Kong with customers


China

South East Asia

India

Brazil

Mexico

R&D Centers in rapidlydeveloping economies

Global InnovationResearch and Development in Rapidly Developing Economies



Corporate Social Responsibility


Corporate Social ResponsibilityEyesight is Not „Normal“ For Everyone

Source: D. Pascolini, S.P. Mariotti, “Global estimates of visual impairment”, Br. J. Ophthalmol. 96, 614 - 618 (2012).

285 millionPeople are visually impaired

1-2 millionpeople go blind per year

39 millionpeople are blind


Worldwide …

Corporate Social ResponsibilityLonglasting Cooperation with Christoffel Mission for the Blind (CBM)


ZEISS and the CBM

The Christoffel Mission for theBlind (CBM) is an international aid organization.

ZEISS and the CBM havebeenpartners for many years: ZEISS supports the CBM in events and with products for itsprojects in Africa, Asia and South America.

11-year-old Kumar from Nepal has been given the gift of sight thanks

to a cataract operation

Corporate Social ResponsibilitySupporting Doctors to Bring Highest Level of Clinical Care to TheirPatients All Over The World


Support for the Fellowship program of the International Council of Ophthalmology (ICO):Every year ZEISS invites ICO fellows – young doctors from developing countries.


ZEISS Medical Technology �Company PresentationContent�ZEISS Medical TechnologyInsights�ZEISS Medical TechnologyThe Power of ZEISS�170 years of company history in InnovationsFoliennummer 5Foliennummer 6Foliennummer 7Foliennummer 8�Represented worldwide�SitesFoliennummer 11Foliennummer 12Foliennummer 13ZEISS Medical Technology�Aspiration & VisionFoliennummer 15Foliennummer 16Foliennummer 17Foliennummer 18Foliennummer 19Foliennummer 20Fascinating Facts �ZEISS Medical TechnologyFoliennummer 22Broad Product Portfolio�We Offer Our Customers an Extensive Portfolio �Foliennummer 24Foliennummer 25The Cataract Workflow�Integrating Products into Systems�Foliennummer 27Foliennummer 28Long-term trends significantly boost our growth �Global MEGA TrendsGlobal MEGA Trends�Several Key Trends are Influencing Our MarketsDemographic Change�The Proportion of Older People is GrowingDemographic Change�Comprehensive Solutions for Typical Age-related Diseases��Demographic Change�Innovations for Age-related Diseases�Technological Change�The Medical Sector is Rapidly Changing�Foliennummer 35Foliennummer 36Technological Leadership�Innovation in Brain Tumor TreatmentGlobalisation �The World is Converging�Globalisation�We Are Well Aware of Our Customers‘ DemandsGlobal Knowledge �Sharing Knowledge Through Worldwide �Training with the ZEISS ACADEMYGlobal Innovation�Research and Development in Rapidly Developing EconomiesFoliennummer 42Corporate Social Responsibility�Eyesight is Not „Normal“ For EveryoneCorporate Social Responsibility�Longlasting Cooperation with Christoffel Mission for the Blind (CBM)Corporate Social Responsibility�Supporting Doctors to Bring Highest Level of Clinical Care to Their Patients All Over The WorldFoliennummer 46

zeiss medical technology company presentation · 2020-05-20 · zeiss. company history. company...

Documents